11/18/2026
Stem cells get a lot of attention in regenerative medicine. But what about fibroblasts? 🔬
While these two cell types share certain biological characteristics, they also have important differences.
One area FibroBiologics is particularly interested in? Stability and scalability.
Fibroblasts can be collected, cultured, and expanded in laboratory settings, making them promising candidates for research and potential cell-based therapeutic development.
In this video, FibroBiologics' Chief Scientific Officer explains why the ability to grow cells consistently and at scale is an important consideration when developing new therapeutic technologies.
Because advancing cell-based medicine isn't just about what cells can do. It's also about how reliably they can be studied, produced, and developed for future applications.
NASDAQ: FBLG
👉 Learn more about the science behind our research: bit.ly/how-immunity-ages